Mentor Earns FDA “Approvable Letter” For Silicone Breast Implant
This article was originally published in The Gray Sheet
Executive Summary
Mentor's Memory Gel silicone breast implant moved one step closer to earning FDA approval July 28 with the receipt of an "approvable letter" listing conditions the company must meet to bring the device to market
You may also be interested in...
Draft Conflict-Of-Interest Policy Affects Status Of Many FDA Cmte. Members
A "significant fraction" of current FDA advisory committee members' eligibility to vote and/or participate in meetings would be curtailed by a revised conflict-of-interest policy, FDA said
Draft Conflict-Of-Interest Policy Affects Status Of Many FDA Cmte. Members
A "significant fraction" of current FDA advisory committee members' eligibility to vote and/or participate in meetings would be curtailed by a revised conflict-of-interest policy, FDA said
Senators question breast implant data
Sens. Dianne Feinstein (D-Calif.) and Olympia Snowe (R-Maine) urge FDA in an Oct. 20 letter to consider "all data collected" by silicone gel breast implant developer Mentor, "whether or not it was originally required" for approval, based on allegations from a former Mentor employee that the company withheld or misrepresented data related to gel leaks. Mentor's Memory Gel silicone breast implants are pending FDA approval; the firm received an "approvable" letter in July 2005 (1"The Gray Sheet" Aug. 1, 2005, p. 18). Public Citizen appealed for a criminal investigation into the whistleblower's claims on Oct. 12 (2"The Gray Sheet" Oct. 16, 2006, p. 5)...